Also categorized in BoardNews:
Germany's Corporate Governance Problem
x hide permanently

Takeda Pushes Back as Group Seeks to Stop $62 Billion Shire Deal

BNN Bloomberg

(Bloomberg) -- Takeda Pharmaceutical Co. Chief Executive Officer Christophe Weber pushed back against dissident shareholders seeking to stop the Japanese drugmaker’s acquisition of Shire Plc, saying he won’t release minutes of boardroom discussions. A group including members of Takeda’s founding family opposes the planned $62 billion acquisition of the U.K.-listed biotech firm, which would rank as the biggest overseas takeover by a Japanese company...

Mentions: Takeover acquisition Japan